Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Burkitt Lymphoma 2Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) 1Neoplasms 1Lymphoproliferative Disorders 1Lymphoma, B-Cell 1Immunoproliferative Disorders 1Graft vs Host Disease 1Bronchiolitis Obliterans Syndrome 1

Interventions

Rituximab 3pirtobrutinib 2Cyclophosphamide 2venetoclax 1tazemetostat 1prednisolone phosphate 1prednisolone acetate 1idelalisib 1fludarabine 1Vincristine 1Prednisolone 1Methylprednisolone 1Methotrexate 1Doxorubicin 1Cytarabine 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Lymphoma, B-Cell × Methotrexate × Clear all
NCT01516580 2026-02-09

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
482 enrolled 1 FDA
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡